Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$814M |
| 2 |
NVIDIA
NVDA
|
+$448M |
| 3 |
Microsoft
MSFT
|
+$394M |
| 4 |
Apple
AAPL
|
+$368M |
| 5 |
Johnson & Johnson
JNJ
|
+$288M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$616M |
| 2 |
Tesla
TSLA
|
+$406M |
| 3 |
Palo Alto Networks
PANW
|
+$400M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$394M |
| 5 |
AT&T
T
|
+$389M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.96% |
| 2 | Technology | 19.64% |
| 3 | Consumer Staples | 10.59% |
| 4 | Consumer Discretionary | 10.5% |
| 5 | Communication Services | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
FRP Holdings
FRPH
$428M
| $880K | ﹤0.01% |
31,600
-30,000
| -49% | -$830K |
|
2727
iShares California Muni Bond ETF
CMF
$4.55B
| $878K | ﹤0.01% |
+14,015
| New | +$876K |
|
2728
Vanguard S&P Small-Cap 600 Value ETF
VIOV
$1.85B
| $875K | ﹤0.01% |
+9,600
| New | +$868K |
|
2729
Dominari Holdings
DOMH
$57.4M
| $874K | ﹤0.01% |
+53,728
| New | +$920K |
|
2730
uniQure
QURE
$3.03B
| $872K | ﹤0.01% |
28,321
-76,079
| -73% | -$2.55M |
|
2731
VirnetX Holding Corp
VHC
$54.4M
| $868K | ﹤0.01% |
10,164
+7,234
| +247% | +$679K |
|
|
SAL
2732
DELISTED
Salisbury Bancorp, Inc.
SAL
| $867K | ﹤0.01% |
34,152
+5,352
| +19% | +$123K |
|
|
SPPI
2733
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $867K | ﹤0.01% |
231,167
-1,425,973
| -86% | -$4.96M |
|
2734
South Plains Financial
SPFI
$845M
| $865K | ﹤0.01% |
37,400
-4,700
| -11% | -$108K |
|
|
DYNT
2735
DELISTED
Dynatronics Corp
DYNT
| $863K | ﹤0.01% |
143,913
+3,900
| +3% | +$22.9K |
|
2736
InnovAge Holding
INNV
$1.54B
| $860K | ﹤0.01% |
+40,337
| New | +$923K |
|
2737
Tompkins Financial
TMP
$1.43B
| $860K | ﹤0.01% |
11,092
-24,800
| -69% | -$2M |
|
|
ATYR
2738
aTyr Pharma
ATYR
$47.6M
| $860K | ﹤0.01% |
176,255
-65,705
| -27% | -$280K |
|
2739
Scully Royalty
SRL
$77.3M
| $856K | ﹤0.01% |
70,367
+5,367
| +8% | +$64.9K |
|
|
FCBP
2740
DELISTED
First Choice Bancorp Common Stock
FCBP
| $856K | ﹤0.01% |
28,100
-41,100
| -59% | -$1.22M |
|
2741
Mirum Pharmaceuticals
MIRM
$6.46B
| $854K | ﹤0.01% |
+49,400
| New | +$885K |
|
|
BWAY
2742
Brainsway
BWAY
$611M
| $851K | ﹤0.01% |
166,794
-34,846
| -17% | -$170K |
|
2743
Passage Bio
PASG
$14.4M
| $851K | ﹤0.01% |
+3,215
| New | +$995K |
|
2744
RLI Corp
RLI
$5.62B
| $851K | ﹤0.01% |
+16,272
| New | +$884K |
|
2745
Vanguard Long-Term Treasury ETF
VGLT
$10B
| $851K | ﹤0.01% |
9,700
-42,100
| -81% | -$3.58M |
|
2746
Invesco FTSE RAFI US 1000 ETF
PRF
$9.79B
| $850K | ﹤0.01% |
26,500
+17,000
| +179% | +$541K |
|
2747
X4 Pharmaceuticals
XFOR
$375M
| $850K | ﹤0.01% |
4,356
-845
| -16% | -$212K |
|
2748
First Trust North American Energy Infrastructure Fund
EMLP
$4.11B
| $849K | ﹤0.01% |
+34,700
| New | +$841K |
|
|
GSKY
2749
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
| $849K | ﹤0.01% |
152,965
-190,231
| -55% | -$1.14M |
|
2750
CNS Pharmaceuticals
CNSP
$8.51M
| – | – |
-1
| Closed | -$1.8M |
|
Similar funds
Renaissance Technologies's Q2 2021 Portfolio in Review
As of Q2 2021, Renaissance Technologies held 3,960 positions worth $80.1B, down 0.34% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $5.63B in Q2 2021, closing 551 positions and reducing 1,699 holdings. Its most notable exit was AT&T, an estimated $389M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Caterpillar worth $227M.
- Renaissance Technologies's largest Q2 2021 buy was Caterpillar: 1,042,778 shares worth $227M.
- Renaissance Technologies added most to Amazon in Q2 2021, an estimated $814M increase.
- Renaissance Technologies's biggest Q2 2021 reduction was Baidu, cutting an estimated $616M.
- Renaissance Technologies fully exited AT&T in Q2 2021, selling an estimated $389M.
- Renaissance Technologies's ten largest holdings make up 12% of its $80.1B portfolio in Q2 2021.
- Renaissance Technologies opened 701 new positions and closed 551 in Q2 2021.
- Renaissance Technologies's portfolio value fell 0.34% quarter-over-quarter to $80.1B.
Based on Renaissance Technologies's 13F filing for Q2 2021, filed 13 Aug 2021.